Media
Press releases
-
AlzeCure achieves Last Patient Last Visit (LPLV) in its phase II clinical trial of the non-opioid ACD440 in neuropathic pain
March 13, 2023
-
AlzeCure participates at Redeye Alzheimer Seminar on March 15
March 7, 2023
-
AlzeCure publishes its Year-end report for January – December 2022
February 24, 2023